$3-$ Could the La Roche Posay brand build upon its medical heritage and therapeutic products with a clinical brand value proposition focused on specific indications $($e$.$g$.,$ acne, psoriasis$)$ and concurrently expand to add new products targeting non$-$pathological audiences with a more generalized and emotional skin care message? Or$,$ should the company invest in developing non$-$therapeutic brands and$/$or sub$-$brands to distance these types of products from the La Roche Posay brand?